Juha O. Rinne

Research.com Recognitions

• 2026 - Research.com Neuroscience in Finland Leader Award
• 2025 - Research.com Neuroscience in Finland Leader Award
• 2023 - Research.com Neuroscience in Finland Leader Award
• 2022 - Research.com Neuroscience in Finland Leader Award

Overview

Best Publications

• Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

  Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  1712
  Citations

• C-11-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

  Juha O Rinne;David J Brooks;Martin N Rossor;Nick C Fox

  1003
  Citations

• The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.

  T Pohjalainen;J O Rinne;K Någren;P Lehikoinen

  839
  Citations

• Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

  Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol

  710
  Citations

• Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

  Petri Luoma;Atle Melberg;Juha O Rinne;Jyrki A Kaukonen

  642
  Citations

• Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study

  A. Okello;J. Koivunen;P. Edison;H. A. Archer

  609
  Citations

• A Phase II Trial of Tideglusib in Alzheimer's Disease

  Simon Lovestone;Mercè Boada;Bruno Dubois;Michael Hüll

  549
  Citations

• Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.

  Nina Mars;Jukka T Koskela;Pietari Ripatti;Tuomo T J Kiiskinen

  527
  Citations

• The use of PET in Alzheimer disease

  Agneta Nordberg;Juha O. Rinne;Ahmadul Kadir;Bengt Långström

  512
  Citations

• Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease

  P. M. Mattila;J. O. Rinne;H. Helenius;D. W. Dickson

  502
  Citations

• Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

  P Edison;C C Rowe;J O Rinne;S Ng

  474
  Citations

• Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra.

  J O Rinne;J Rummukainen;L Paljärvi;U K Rinne

  467
  Citations

• Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.

  Valtteri Kaasinen;Harry Vilkman;Jarmo Hietala;Kjell Någren

  461
  Citations

• Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.

  Juha O. Rinne;Raija Portin;Hanna Ruottinen;Elina Nurmi

  445
  Citations

• Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.

  Sargo Aalto;Anna Brück;Matti Laine;Kjell Någren

  411
  Citations

• PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

  N. M. Kemppainen;S. Aalto;I. A. Wilson;K. Någren

  379
  Citations

• Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study.

  Satu K Jääskeläinen;Juha O Rinne;Heli Forssell;Olli Tenovuo

  356
  Citations

• Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

  Unknown

  355
  Citations

• Striatal dopamine D1 and D2 receptors in burning mouth syndrome.

  Nora Hagelberg;Heli Forssell;Juha O Rinne;Harry Scheinin

  353
  Citations

• Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease

  Yi Li;Yi Li;Juha O. Rinne;Lisa Mosconi;Elizabeth Pirraglia

  341
  Citations

• An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome

  H.M. Ruottinen;M. Partinen;C. Hublin;J. Bergman

  337
  Citations